Position in AMLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,219,314
+$1,415,427 QoQ
Shares Held
159,663
+139.9% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,048 across 61 Drug Manufacturers - Specialty & Generic names. AMLX ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,219,314 | 159,663 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $803,887 | 66,547 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $487,119 | 35,844 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $564,008 | 87,989 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $191,404 | 54,069 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $210,190 | 55,606 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $455,410 | 140,559 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $109,270 | 57,511 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $1,163,713 | 409,759 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $1,058,191 | 71,888 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $1,665,568 | 90,965 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,104,684 | 190,296 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,983,877 | 101,700 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $1,836,451 | 49,701 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $542,281 | 19,264 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $118,102 | 6,132 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $57,786 | 4,497 | Shares | Defined | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||